NCT06646250 NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
| NCT ID | NCT06646250 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Olavs Hospital |
| Condition | Preterm |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-10-20 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2024-10-20 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Non-invasive tools for monitoring of course of disease are important and necessary in the treatment of pre-term/premature infants and sick neonates. For many years, the ultrasound group in Trondheim has been at the forefront in the development of new ultrasound technology for the diagnosis and monitoring of disease. Several methods previously developed in this research group are today widely used in hospitals around the world. In this project the investigators aim to test a new ultrasound technology that allows continuous monitoring of cerebral blood flow in sick neonates and pre-term children. This technology was CE-certified in October 2022, and in this project the investigators will test the CE-certified version with the newest available approved software.
Eligibility Criteria
Inclusion Criteria: * Open fontanelle * Healthy preterm or term born neonates * Neonates with a medical condition of interest according to the different cohort studies: patent ductus arteriosus, perinatal asphyxia, stroke, pulmonary hypertension, congenital heart condition or infection/sepsis/meningitis * Neonates in need of procedures Exclusion Criteria: * Caregivers not understanding/speaking Norwegian or English * Caregivers not giving their consent
Contact & Investigator
Siri Ann Nyrnes, MD, PhD
PRINCIPAL INVESTIGATOR
Childrens Clinic, St. Olavs University Hospital and NTNU
Frequently Asked Questions
Who can join the NCT06646250 clinical trial?
This trial is open to participants of all sexes, aged 0 Minutes or older, up to 12 Months, studying Preterm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06646250 currently recruiting?
Yes, NCT06646250 is actively recruiting participants. Contact the research team at siri.a.nyrnes@ntnu.no for enrollment information.
Where is the NCT06646250 trial being conducted?
This trial is being conducted at Trondheim, Norway.
Who is sponsoring the NCT06646250 clinical trial?
NCT06646250 is sponsored by St. Olavs Hospital. The principal investigator is Siri Ann Nyrnes, MD, PhD at Childrens Clinic, St. Olavs University Hospital and NTNU. The trial plans to enroll 180 participants.